Georgian Biomedical Preparations to be Used by a US Owned Company; Bacteriophage-based Antibacterial Products from World-Renowned Eliava Institute to be Used by US Owned Phage Therapy Center in Mexico.
"We are delighted that through this cooperation with the Eliava Institute, Phage Therapy Center Mexico will now be able to provide better access to this medical technology," said Ronald Goossens, president PII. "We look forward to making bacteriophage treatments more broadly available in the future".
"The scientists at Eliava Institute are pleased to work with PII in treating patients on the American Continent using our phage preparations and look forward to educating the west on the benefits of bacteriophage technology," said Dr. Teimuraz Chanishvili, Institute Director.
During the 1930's and 40's, bacteriophages were utilized in the United States to treat infections. The use of phages and research were subsequently dropped in the west in favor of antibiotics that became the panacea for treating all infections. The Eliava Institute, however, continued research and development of phage therapeutic technologies. Today bacteriophages represent a viable and effective alternative for fighting drug-resistant infections.
Eliava, an 82 year-old Institute of the Academy of Sciences in the Republic of Georgia, is the world's scientific center for bacteriophage research and development. During the 1970s and 80s the Industrial Branch of the Eliava Institute produced bacteriophage products for military and civilian uses all over the Soviet Union.
Phage Therapy Center Mexico, treats antibiotic-resistant infections and provides treatments that have saved people from amputation. www.phagetherapycenter.com
Phage International, Inc. Los Altos, CA, a primary enabler of phage therapy in the western world, is in the process of opening a number of clinics. www.phageinternational.com